Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.
about
Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potencyPotential uses of probiotics in clinical practiceDiscovering probiotic microorganisms: in vitro, in vivo, genetic and omics approachesMechanisms and therapeutic effectiveness of lactobacilliMicrobiome, inflammation, and cancerReview article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.Functional foods and their role in cancer prevention and health promotion: a comprehensive review.A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds.Potential role of probiotics on colorectal cancer preventionProbiotics in the gastrointestinal diseases of the elderly.Lactic acid bacteria and cancer: mechanistic perspective.Diet and cancer: assessing the risk.Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal ProbiomeDietary fibre: a roughage guide.Gut microbiota, immunity, and disease: a complex relationship.The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer.A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.Cancer-preventing attributes of probiotics: an update.Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism.Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment.Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.
P2860
Q24524299-B9367CAF-E5B6-4FB2-B2F0-BBA19CE9290BQ24650990-6709FBEB-C39E-4109-82BB-BE409E0FAF68Q24681377-58ED1628-D149-4733-A64D-89062C236FD0Q27012682-B15F61E0-2F20-4498-9D5A-1C9608C939BCQ27012999-FE08AA3D-1336-49B0-901B-3FB5535A95A1Q27027582-C07E4CEC-668E-4035-AD11-A0B38528941FQ33223485-460A68E4-EBFA-46A0-B90B-0EF0045F891EQ33431282-9CB28D24-BA9E-4E3B-8B22-5ED8076D88D9Q33438678-7547379C-7882-4B56-BA89-B4FDDC5C2BFDQ33622636-E863D83D-96DF-439D-A117-0365A906B330Q33860298-798F98F0-3BC4-4CB7-8765-0345BD47D5E7Q34485634-1DCB8EE1-3A5A-47DE-889C-78A4343FE7A5Q34637436-B272088F-38ED-4D51-9816-EF112AAAD6F9Q34820566-C43AB042-44FA-4E43-9CF5-619CAD35A8D5Q34820603-4118A86C-62BF-4BC4-9DB3-221D02380BB5Q34881370-0258367D-5098-4093-917F-5A34FBAF3407Q35161393-9DB7FC10-4EF2-4D2B-9301-9B75C1C9FB89Q35195785-ACCA71E5-8CFB-4114-8F72-EB123BD0D120Q35571641-649E19A5-BDCF-4CF5-8F1A-8575EACD1AD5Q35900047-493CEE37-FC4E-4D5D-AAB9-E40060F49A5BQ37174716-15642170-6FF1-4A74-9186-D7F56A8B9AA6Q37333713-40085933-920F-4B98-821C-2F85B5B23C58Q38143713-0997A9B8-0851-4267-8BF1-2B21EF99036EQ39414117-2954FC23-9FDE-4938-BAEC-EFDF7B9A8B69Q43148199-46945A92-5777-4361-99DC-96F8D11E81D8Q43564045-1EF8BD9B-D9AD-405B-BADA-69588B534C6DQ44197112-7F30175E-CB9F-4419-92C6-48724345FFA2Q44502414-641CD939-4302-4B4F-98C1-B4363B818214
P2860
Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@en
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@nl
type
label
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@en
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@nl
prefLabel
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@en
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@nl
P2093
P356
P1433
P1476
Bifidobacterium longum and lac ...... c aberrant crypt foci in rats.
@en
P2093
P304
P356
10.1093/CARCIN/18.3.517
P407
P577
1997-03-01T00:00:00Z